Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension

[1]  V. Basevi,et al.  Standards of Medical Care in Diabetes—2012 , 2011, Diabetes Care.

[2]  G. Bakris,et al.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.

[3]  L. Borrell,et al.  Social disparities in periodontitis among United States adults 1999-2004. , 2008, Community dentistry and oral epidemiology.

[4]  Silvio E. Inzucchi,et al.  Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.

[5]  F. Salvi,et al.  Renin–angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans , 2008, Journal of hypertension.

[6]  M. Melino,et al.  The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. , 2008, Clinical therapeutics.

[7]  J. Tuomilehto,et al.  Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: The ACCOMPLISH Study , 2008, Blood pressure.

[8]  Roland Chen,et al.  Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. , 2007, Archives of internal medicine.

[9]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[10]  A. Pessina.  Target organs of individuals with diabetes caught between arterial stiffness and damage to the microcirculation. , 2007, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[11]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[12]  Piotr Ponikowski,et al.  2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, European heart journal.

[13]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[14]  C. Lau,et al.  Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004 , 2007, Hypertension.

[15]  Michael F O'Rourke,et al.  Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. , 2005, Hypertension.

[16]  M. Volpe.  Hypertension therapy: Mixing, matching, and meeting targets , 2004, Advances in therapy.

[17]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[18]  M. Moser.  Treatment of Hypertension in the Very Elderly: a Clinician's Point of View , 2003, Journal of clinical hypertension.

[19]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[20]  E. Schiffrin,et al.  Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. , 2003, Archives of internal medicine.

[21]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[22]  F. Messerli.  Vasodilatory edema: a common side effect of antihypertensive therapy. , 2001, Current cardiology reports.

[23]  K. Watson.  Cardiovascular risk reduction among African Americans: a call to action. , 2008, Journal of the National Medical Association.

[24]  G. Mcinnes.  How important is optimal blood pressure control? , 2004, Clinical therapeutics.

[25]  M. Weir.  Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance. , 2003, Journal of clinical hypertension.

[26]  Philip Raskin,et al.  The treatment of hypertension in adult patients with diabetes. , 2002, Diabetes care.